The Swedish AI software company Qlucore AB (“Qlucore” or “the Company”) – with more than 200 international customers – today announces that it has secured SEK 30 million before transaction costs in a pre-IPO private placement. The raised capital will predominantly be used to accelerate sales activities and expand the technical team prior to an […]
Partnership combines Viroclinics-DDL’s diagnostic and high-throughput sequencing experience with ENPICOM’s expertise in bioinformatics and immunomics ‘s-Hertogenbosch (The Netherlands) – Life Science Newswire – Viroclinics-DDL, a state-of-the-art Contract Research Organization specialized in molecular diagnostic testing and assay development, and ENPICOM, an innovative bioinformatics software engineering company, announced the approval of their joint MIT Zuid subsidy (SME […]
IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, notes that portfolio company Oxford Nanopore Technologies Ltd (“Oxford Nanopore”) has today announced that it has informed its shareholders that it has started the process of preparing for a potential Initial Public Offering (“IPO”). Whilst the timing of a potential […]
Transaction combines SomaLogic’s comprehensive proteomics technology platform with CM Life Sciences II, a leading life science-focused SPAC, led by affiliates of institutional investors Casdin Capital and Corvex Management. Combination is expected to provide up to $651 million in cash proceeds for SomaLogic, expanding the cash on its balance sheet to $686 million to catalyze organic […]
UPPSALA, Sweden — Olink Holding AB (publ) (Nasdaq: OLK) (“Olink” or the “Company”), today announced the pricing of its initial public offering of 17,647,058 common shares in the form of American Depositary Shares (“ADSs”), including 4,411,764 ADSs to be sold by the selling shareholders, at a price to the public of $20.00 per ADS, with […]
NEW YORK — Avista Capital Partners (“Avista”), a leading private equity firm focused exclusively on healthcare, today announced that it has signed a definitive agreement to invest in eMolecules (“eMolecules,” or the “Company”), a novel and fast-growing e-procurement platform for high-value chemicals and bioreagents used by the leading pharmaceutical companies in drug discovery. Financial terms […]
Strong financial performance and the achievement of other key milestones demonstrate the growing strength of Synthace’s offering within the biopharma and biotech industries London, UK: Synthace Ltd, developers of Antha, the cloud-based software platform for automating and improving the success rate of biological processes, today announced it increased its annual recurring revenue by 225% compared […]
Teledyne Technologies Incorporated (NYSE:TDY) announced today that it has completed all permanent financing for the pending acquisition of FLIR Systems, Inc. (NASDAQ:FLIR). Given the permanent financing, together with certain continuing debt, Teledyne expects its weighted average borrowing cost to be less than two percent upon closing the acquisition. Today Teledyne closed an offering of $3.0 […]
FLIR to Team with Purdue University to Develop Novel Ion Separation and Analysis Technologies with Funding from the Defense Threat Reduction Agency ARLINGTON, Va. ― FLIR Systems, Inc. (NASDAQ: FLIR) announced it has won a contract worth up to $8.0 million from the United States Defense Threat Reduction Agency’s Joint Science and Technology Office (DTRA JSTO) […]
WELLESLEY, Mass. — Ampersand Capital Partners announced a minority investment in Magritek, a global leader in benchtop and portable NMR instruments for life sciences and other industries. Founded in 2004, Magritek is a New Zealand company with operations in Aachen, Germany, Philadelphia, PA, and Wellington, NZ. Magritek’s flagship Spinsolve benchtop NMR instruments provide resolution and sensitivity previously unavailable at the laboratory […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
